Noninvasive tools to quantitate transgene expression directly are a prerequisite for clinical gene therapy. We established a method to determine location, magnitude, and duration of low-densitiy lipoprotein (LDL) receptor (LDLR) transgene expression after adenoviral gene transfer into LDLR-deficient Watanabe hypercholesterolemic rabbits by following tissue uptake of intravenously injected 111 In-labeled LDL using a scintillation camera. Liver-specific tracer uptake was calculated by normalizing the counts measured over the liver to counts measured over the heart that represent the circulating blood pool of the tracer (liver/heart (L/H) ratio). Our results indicate that the optimal time point for transgene imaging is 4 h after the tracer injection. Compared with control virusinjected rabbits, animals treated with the LDLR-expressing adenovirus showed seven-fold higher L/H ratios on day 6 after gene transfer, and had still 4.5-fold higher L/H ratios on day 30. This imaging method might be a useful strategy to obtain reliable data on functional transgene expression in clinical gene therapy trials of familial hypercholesterolemia.
Introduction
Clinical gene therapy studies require noninvasive tools to evaluate the efficacy of gene transfer. 1, 2 Ideally, such an approach should also allow to quantitate functional expression of the therapeutic transgene in vivo repetitively. Thereby, the location, magnitude, and duration of the expression of the therapeutic gene could be monitored and followed over time.
Most of the studies reporting gene transfer imaging so far were performed in the field of cancer gene therapy and did not directly monitor the expression of the gene of interest. [1] [2] [3] The activity of enzyme systems such as herpes simplex virus (HSV) thymidine kinase or cytosine deaminase has been assayed by the use of radiolabeled substrates. 1, 3 In addition, bicistronic vector systems containing, besides the gene of interest, a reporter construct that would be accessible to radioisotope imaging have been reported. 2, 4 Furthermore, gene therapy vectors have been directly coupled with radioisotopes 5, 6 or contrast media. 7 These approaches, however, allow mainly an assessment of tissue sites of the expression and transduction efficacy of the vector itself and not in the first line of the therapeutic gene.
Familial hypercholesterolemia (FH) is one of the most common genetic diseases. 8 It has an autosomal dominant genetic trait with an incidence of affected homozygotes of one in one million of the general population. Patients have defects in the low-density lipoprotein (LDL) receptor (LDLR), develop severe hypercholesterolemia, and die because of complications of premature atherosclerotic cardiovascular disease. 8 Liver is the clinically most important site of the LDLR expression, since liver transplantation is able to cure FH. 9 Owing to these features, FH was among the first diseases for the development of liver-directed clinical gene therapy strategies. Two established animal models are available, LDLR knockout mice 10 and Watanabe hypercholesterolemic (WHHL) rabbits. 11 The latter is more closely resembling human disease, because of the distribution of the cholesterol between lipoprotein subclasses (LDL:HDL ratio) in the rabbits, which is most likely due to the presence of cholesteryl ester transfer protein, and because of their susceptibility to spontaneous atherosclerosis without high-fat dietary challenge. 12 In both models, proof of principle of liver-directed gene therapy for FH has been demonstrated. 10, 13, 14 FH was also one of the first diseases targeted with a clinical gene therapy protocol in humans. 15 To date, nuclear medicine imaging techniques uniquely provide the necessary sensitivity to (i) detect unwanted ectopic expression and (ii) judge successful gene delivery and expression. The model of FH is particularly suited for the development of a protocol to assess functional transgene expression in vivo, since native LDL is taken up by a highly specific receptor localized on the cell surface, the LDLR. 8 Therefore, the aim of the present study was to develop a sensitive noninvasive method to monitor functional gene expression of the LDLR following adenovirusmediated gene transfer into WHHL rabbits repetitively, an established animal model of human FH.
Results

Gene transfer of AdCMV.LDLR decreases plasma cholesterol in WHHL rabbits
The injection of WHHL rabbits with AdCMV.LDLR resulted in a significant time-dependent decrease of plasma total cholesterol with the peak effect being observed at day 6 with a decrease by 46% compared with baseline values (Figure 1a ). Up to day 30, plasma TC levels gradually normalized consistent with previous reports. 13 Fast protein liquid chromatography (FPLC) analysis at day 0 (Figure 1b) revealed the typical lipoprotein profile of a WHHL rabbit with the bulk of plasma cholesterol within the LDL fraction. The reduction in TC at day 6 after AdCMV.LDLR injection was mainly due to a decrease of cholesterol contained within the LDL and VLDL fractions (Figure 1b) . At day 30, however, VLDL cholesterol was increased, while LDL cholesterol was still decreased as compared with the day 0 profiles. There was no significant change in the plasma TC levels (Figure 1a ) or in the lipoprotein profile (data not shown) over time in control virus-injected rabbits.
Scintillation camera imaging is specific for the functional detection of LDLR activity in vivo
Before performing the imaging study, we carried out a tracer validation experiment comparing different batches of In-LDL tracer prepared using a 1:1 ratio of DTPA to LDL were superimposable, indicating the physiological integrity of this 111 In-LDL tracer. On the other hand, increasing the DTPA to LDL ratios to 5:1 and 10:1 resulted in a slower in vivo catabolism, indicating that the interaction between the tracer and the LDLR was impaired. The subsequent studies were, therefore, all carried out using 111 In-LDL prepared with a DTPA to LDL ratio of 1:1. Figure 3 illustrates the image obtained with a gamma scintillation camera 4 h after the injection of a New Zealand White (NZW) rabbit having intact LDLR activity with the 111 In-LDL tracer. The liver is the organ with the highest LDLR activity, the signals detected over the heart represent the circulating blood In-LDL catabolism in vivo in NZW rabbits in comparison to 125 I-labeled LDL. Tracers were prepared as described in Materials and methods section, injected into NZW rabbits possessing intact LDLR activity, and the decay of radioactivity in plasma was followed over time.
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Optimal time point for imaging functional transgene expression using a scintillation camera is 4 h after the tracer injection
We next aimed to define the optimal time point to quantitate the hepatic tracer uptake following adenoviral gene transfer. Therefore, serial scans were performed on day 6, the day of peak transgene expression. Rabbits were injected with the 111 In-LDL tracer and gamma camera images were obtained at 15 min, 1, 4, and 24 h ( Table 1) . The tracer accumulation in the liver related to the circulating blood pool of the tracer (liver/heart (L/H) ratio) increased over time in the AdCMV.LDLR-treated rabbits, indicating specific uptake of the labeled LDL into the liver. In contrast, AdCMV.LacZ-or PBS-injected rabbits did not show any significant change in their L/ H ratios over time (Table 1) . Using this method, we were at all chosen time points able to discriminate between the group of AdCMV.LDLR-treated animals and the groups of control rabbits clearly. Peak signals were obtained at 24 h, but were, however, not statistically significantly different from the 4 h values. We therefore chose 4 h after the tracer injection as the optimal time point for the imaging studies.
Scintillation camera imaging is a sensitive method to follow functional LDLR transgene expression over time in vivo Figure 4a shows an example of the time course of two independent WHHL rabbits injected with 1 Â 10 12 plaque forming units (PFU) of AdCMV.LDLR on day 0. Pictures were taken with a gamma camera 4 h after the injection with the 111 In-LDL tracer. There is no specific tracer uptake before adenovirus administration reflecting the homozygous LDLR deficiency of the WHHL rabbit. After liver-specific restoration of LDLR activity by adenoviral gene transfer, there is a strong liver-specific signal clearly visible on day 6 that lasts, although weaker, until day 30 after gene transfer.
The quantitation of the L/H ratios throughout this time course is illustrated in Figure 4b . At day 0, the L/H ratios of AdCMV.LDLR-and control virus-injected WHHL rabbits were identical (1.470.2 versus 1.370.1, respectively), whereas at day 6 AdCMV.LDLR-administered rabbits had significantly higher values (11.274.2 versus 1.670.2, respectively, Po0.001). This effect extended throughout day 30 (6.371.5 versus 1.470.2, respectively, Po0.001). In comparison, NZW rabbits that have a normal LDLR activity demonstrate a L/H ratio of 4.270.9 ( Figure 4b ). The specificity of the signal at day 30 was confirmed independently by immunohistochemistry for the human LDLR in the livers of AdCMV.LDLRinjected rabbits (Figure 5a-c) and by LacZ staining in case of control virus-injected rabbits (data not shown). Transgene activity was high at day 6 (Figure 5b ), but still detectable even at day 30 after adenovirus administration (Figure 5c ). In addition, lipoprotein kinetic studies performed on day 30 after adenovirus injection using 125 I-LDL as the tracer revealed still faster catabolism in the group of AdCMV.LDLR-injected rabbits compared with AdCMV.LacZ-injected animals, although this difference was not statistically significant (data not shown). Taken together, these data demonstrate that scintillation camera imaging is a sensitive method to follow functional transgene expression in vivo.
Discussion
In this study, we demonstrate that repetitive highly sensitive imaging of successful LDLR gene transfer in the rabbit model of human FH is feasible using 111 In-labeled LDL and a scintillation camera. This approach allowed us to visualize the location, magnitude, and duration of the expression of the therapeutic gene over a period of 30 days in the same experimental animals directly. Our study therefore describes an important prerequisite for a clinical protocol to monitor transgene expression noninvasively in a human gene therapy trial potentially.
The model of FH offers the advantage that LDL is internalized via a highly specific cell surface receptor, the LDLR. 8 By labeling LDL, tissue uptake over time as an effect of receptor activity can be followed. 16, 17 We chose 111 In as a radiotracer, because previous studies have indicated that used in a certain molar ratio LDL labeled with 111 In behaves in in vivo kinetic studies metabolically as 125 I-labeled LDL. 17, 18 These data were confirmed by In-LDL was found to be associated with liver nonparenchymal cells as opposed to the parenchymal cell population. 17 Since native LDL is primarily internalized via the LDLR on hepatocytes, oxidized, or otherwise modified LDL is in the liver preferentially targeted to the Kupffer cells, where it is taken up by an array of different scavenger receptors. 19, 20 Therefore, these data from the literature show that 111 In labeling does not result in extensive oxidative or chemical modifications of the LDL particle. In addition,
111
In is a strong emitter of high-energy photons, so that the sensitivity of the detection by the use of scintillation cameras is high. A practical alternative to labeling LDL with 111 In might be the use of 99m Tc-labeled LDL. 17,21,22 99m Tc is also emitting photons suitable for imaging studies and has a half-life of only 6.02 h. The methodology used in the present study also bears the potential of being transferred to other transgenes that are ligands with a specialized cell surface receptor mediating their cellular uptake. However, a methodological disadvantage Imaging of LDLR gene transfer UJF Tietge et al of using a scintillation camera could be seen in the low spatial resolution as well as the nontomographic manner of this technique. Single photon emission computed tomography or positron emission tomography might represent significant technical advancements for future studies in the attempt to take functional transgene imaging of the LDLR to the clinics.
Another methodological consideration needs to be taken into account when interpreting the data of this study. Although quantifiable, our scintigraphic results, have due to the data acquisition profile, to some extent a qualitative character. Accumulating a total of 100 000 counts 4 h after the tracer injection, scaling each picture to its own maximum and calculating L/H ratios from these data might result in a relative overestimation of lower expression levels, that is, the activity uptake.
Thus far, studies reporting transgene imaging have centered on two different approaches: (i) the use of radiolabeled substrates to assess the activity levels and tissue sites of the expression of suicide enzymes such as HSV thymidine kinase or cytosine deaminase, 1, 3 and (ii) bicistronic vector systems to monitor tissue sites infected by the adenovirus and to assess more in general adenoviral expression levels. 2, 4 The latter method only indirectly evaluates transgene expression. Other indirect methods comprise the use of vectors that are either radiolabeled for the detection by scintillation camera systems 5, 6 or gadolinium labeled to be detected by magnetic resonance imaging technology. 7 Another study aimed at using adenoviruses that express transgenes suited for noninvasive imaging under the control of tissue-specific promoters to help in the detection of metastatic lesions. 23 In addition, nonradioactive strategies to visualize the expression of certain transgenes following gene transfer are being developed. 24 Interestingly, we detected statistically significant differences in the L/H ratios between AdCMV.LDLR-and control virus-injected rabbits throughout day 30 after adenovirus administration. At this time point, plasma total cholesterol was already normalized. However, plasma total cholesterol levels might not be a very sensitive readout to judge the metabolic effects of the gene transfer, as (i) immunohistochemistry showed that the expression of the human LDLR protein in the liver was still detectable on day 30 after gene transfer, and (ii) injected radiolabeled 125 I-LDL was still being catabolized faster in the AdCMV.LDLR-administered animals compared with controls on day 30. In addition, all images from LDLR-expressing adenovirus-treated rabbits were clearly distinguishable by the L/H ratios from animals that had received the control adenovirus. We therefore believe that the data obtained with our imaging technique represent the imaging of transgene expression within the livers of treated animals and are not due to unspecific adenovirus-associated effects. Furthermore, FPLC analysis on day 30 revealed still decreased plasma LDL cholesterol levels compared with day 0, while VLDL cholesterol was clearly increased. Similar FPLC profiles with increased VLDL cholesterol after LDLR gene transfer have been reported in mice, 10 and might reflect a compensatory increase in VLDL production rates in response to increased cholesterol influx into the liver via the restored LDLR.
In summary, we have developed a sensitive noninvasive imaging approach to detect transgene activity following LDLR gene transfer repetitively. This technique might be easily applicable to human studies allowing one to obtain reliable data on the time course and the extent of transgene expression in gene therapy protocols designed to correct the metabolic defect of FH.
Materials and methods
Construction of recombinant adenoviruses
The construction of the recombinant adenoviruses AdCMV.LDLR, expressing the human LDLR gene, and the control virus AdCMV.LacZ has been described. 25 Recombinant adenovirus was expanded in 293 cells, purified by cesium chloride ultracentrifugation, and stored until use in 10% glycerol-phosphate-buffered saline (PBS) as described. 26 Lipid and lipoprotein analysis Plasma total cholesterol was measured enzymatically using a commercially available kit (Boehringer Mannheim, Mannheim, Germany). Plasma samples (200 ml) were subjected to FPLC using a Superose 6 column (Pharmacia LKB Biotechnology, Uppsala, Sweden) as described. 27 Lipoprotein fractions of 500 ml were collected and individual fractions assayed for total cholesterol concentrations.
Preparation of LDL tracers
LDL was freshly isolated from human plasma by sequential ultracentrifugation (1.019odo1.063) as described. 28 Protein content was assayed using the BCA reagents (Pierce, Rockford, IL, USA). LDL was labeled in two different ways: (i) LDL was radiolabeled with 125 I by the iodine monochloride method, 29 yielding iodination efficiencies between 8 and 20%. The iodinated LDL was purified by size exclusion chromatography using Sephadex G25 columns (Pharmacia LKB Biotechnology, Uppsala, Sweden). For in vivo kinetic studies, rabbits were injected with 15 mCi of 125 I-LDL.
(ii) For indium labeling (half-life: 2.83 days), LDL was washed with PBS, pretreated with 1% bovine serum albumin, and concentrated using Centricon-10 microconcentrators (Amicon, Witten, Germany). DTPA anhydride was conjugated to lysine residues of the apolipoprotein part of the LDL particle by an acylation reaction using cyclic DTPA dianhydride as described. 16, 18 Lysine residues have been shown to be important for the binding of apoE and apoB to the LDLR. 8 To assess the effect of this conjugation reaction on the receptor-binding properties of the LDL particle, initially different molar ratios of DTPA to LDL were used and the effects on the in vivo catabolic rates were checked in NZW rabbits in comparison to 125 Ilabeled LDL (see Figure 2) . Based on the results of this tracer validation experiment, the conjugation was finally carried out at a molar ratio of 1:1. The yield of this reaction was calculated after separation of free DTPA and LDL-DTPA conjugate using thin layer chromatography. Subsequently, to 1 mg of protein 2.5 mCi of 111 InCl 3 were added, which is rapidly chelated by the LDL-DTPA conjugate. Radiolabeled conjugate was purified by Sephadex G-25 permeation chromatography. The labeling efficiencies were 10-20%. After TCA precipitation, greater than 95% of the radioactivity was found to be associated with the protein fraction of the 111 In-LDL In-DTPA-LDL by agarose-gel electrophoresis, followed by slicing of the gels and g counting. Native LDL migrated in the b-position as expected, and both the tracer preparations exhibited similar migration characteristics. Importantly, the labeled LDL preparations migrated each as a single band (data not shown). The biological integrity of the indiumlabeled LDL tracer was checked for each batch of labeled 111 In-LDL by in vivo kinetic studies in comparison to 125 I-LDL in NZW rabbits. In addition, lipoprotein fractions from plasma obtained at the 15 min, 1, 4, and 6 h time points of the kinetic tracer validation study were separated by FPLC analysis using a Superose 6 column (Pharmacia, LKB Biotechnology, Uppsala, Sweden) and assayed for 111 In and 125 I on a 1282 Compugamma gamma counter (Pharmacia LKB, Freiburg, Germany). This way, we confirmed that greater than 90% of the total plasma radioactivity was contained within the LDL fraction at these time points. In addition, another noteworthy property of the tracer is that following LDLR-mediated uptake 111 In-LDL is rapidly degraded in the lysosomes. The
111
In is then cleared from the liver to the blood stream and excreted by the kidneys within minutes (compare Figure 3) .
Animal studies
Female 6-month-old WHHL rabbits were obtained from Professor Dimigen (Laboratory Animal Facilities, University Hospital Eppendorf, Hamburg, Germany) and NZW rabbits were purchased from Charles River (Sulzfeld, Germany). The animals were caged in animal rooms with alternating 12 h periods of light (0700-1900) and dark (1900-0700) with ad libitum access to water and rabbit chow diet. All experiments were performed in accordance with the German National Research Council Criteria and approved by the local government authorities. Rabbits were injected on day 0 with 1 Â 10 12 PFU of recombinant adenovirus in a total volume of 5 ml PBS by the ear vein. Blood samples were taken by the ear artery after an overnight fast at the time points indicated. At different time points following the injection of recombinant adenoviruses, control virus-and AdCMV.LDLRinjected rabbits were killed to assess the hepatic expression of the transgenes. The LDLR expression was checked by immunohistochemistry. The staining was performed using a monoclonal mouse anti-human LDLR antibody (Amersham, Braunschweig, Germany), followed by a biotinylated rabbit anti-mouse secondary antibody (Dako, Hamburg, Germany). The immunoreaction was visualized by fluorescein isothiocyanate-labeled extravidin (Sigma, Deisenhofen, Germany). In control virus-injected animals, the expression of the transgene was assayed after cryosectioning by staining for LacZ as described. 13 For imaging studies, rabbits were anesthetized with a mixture of ketamine (25 mg/kg) and midazolam (2 mg/ kg). Imaging was performed with a gamma scintillation camera (Siemens, ZLC 3700, Munich, Germany). For data acquisition, the energy peaks of both 172 and 247 keV were used, each with a window width of 15%. The image matrix size was 256 Â 256. A total of 100 000 counts were accumulated for each image and each image was scaled to its own intensity maximum. Rabbits were injected with 10 mCi
111
In-labeled LDL. This corresponded to a total amount of LDL protein between 60 and 100 mg per rabbit depending on the batch of tracer prepared. This amount represents far less than the thousandth part of total LDL protein in WHHL rabbits and is therefore not expected to have a significant impact on LDL pool size. Images were obtained at 15 min, 1, 4, and 24 h after injection of the tracer. To quantitate the hepatic tracer uptake in individual animals, we used the ratio of the absolute counts detected over the liver divided by the signals measured over the heart (to correct for the circulating blood pool of the tracer at each time point).
Statistical analysis
Values are presented as mean7s.d. unless otherwise indicated. The results were analyzed by ANOVA and Student's t-test using the Statistical Package for the Social Sciences (SPSS) Software. Statistical significance for all comparisons was assigned at Po0.05.
